Answers are grounded in this paper and cite their sources.
Case report reveals successful precision surgery for multifocal neuroendocrine tumors in a patient with lymphatic metastasis, indicating future potential for similar treatments.
SI-NETs: Small Intestinal Neuroendocrine Tumors; TMB: Tumor mutation burden; NET (G1): Grade 1; Mut/Mb: Total number of somatic/acquired mutations per coding area of a tumor genome; mCi: millicurium; TP53: cellular tumor antigen P53 (PTHR11447:SF6); RB1: Retinoblastoma associated protein (PTHR13742:SF17); CDKN1B: Cyclin dependent kinase inhibitor 1B (PTHR10265:SF9); KRAS: GTPase KRAS (PTHR24070:SF388); NRAS: GTPase NRAS (PTHR24070:SF189); MET: Hepatocyte growth factor receptor; HGNC: 7029
No takes yet. Share an insight, caveat, or question.
Losada et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: